Seeking Alpha

Mylan (MYL +1%) gains on an upgrade to Buy from at Goldman, citing improved earnings visibility...

Mylan (MYL +1%) gains on an upgrade to Buy from at Goldman, citing improved earnings visibility and an underestimated margin expansion led by the company's EpiPen product mix shift.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)